Edition:
United States

ESSA Pharma Inc (EPIX.OQ)

EPIX.OQ on NASDAQ Stock Exchange Capital Market

0.22USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
31,543
52-wk High
$3.59
52-wk Low
$0.21

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.067
Jun '17 0.00 0.116
Mar '17 0.00 -0.262
Dec 0.00 0.046
FY 2016 Sep '16 0.00 -0.146
Jun '16 0.00 -0.133
Mar '16 0.00 -0.039
Dec 0.00 -0.176
FY 2015 Sep '15 0.00 0.024
Jun '15 0.00 -0.291
Mar '15 0.00 -0.196
Dec 0.00 -0.085
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-17 2 0.00 0.00 0.00 --
Year Ending Sep-17 2 0.00 0.00 0.00 --
Year Ending Sep-18 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-17 2 -0.22 -0.18 -0.26 --
Year Ending Sep-17 2 -0.66 -0.55 -0.78 --
Year Ending Sep-18 1 -0.68 -0.68 -0.68 --
Sales and Profit Figures in Canadian Dollar (CAD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta -- 0.82 0.91
Price to Sales (TTM) -- 122.78 5.95
Price to Book (MRQ) -- 23.45 5.68
Price to Tangible Book (MRQ) -- 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions -- 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -- 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 54.07 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago 66.28 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 1.34 5.62 3.56
LT Debt to Equity (MRQ) -- 16.22 13.38
Total Debt to Equity (MRQ) -- 18.71 19.38
Interest Coverage (TTM) -- -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -- -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -- -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -- -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,314,532 851,801,741
Net Income/Employee (TTM) -- -1,997,855 99,542,701
Receivable Turnover (TTM) -- 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.00 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.20 -9.39 11.31
Return on Assets - 5 Yr. Avg. -- 0.28 12.28
Return on Investment (TTM) -104.60 -11.76 14.43
Return on Investment - 5 Yr. Avg. -- 3.42 16.07
Return on Equity (TTM) -- -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 68.34 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ESSA Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 23.55%
# of Holders: 10
Total Shares Held: 6,854,867
3 Mo. Net Change: -3,019,112
# New Positions: 3
# Closed Positions: 4
# Increased Positions: 5
# Reduced Positions: 5
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.